sparfloxacin has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, DH; He, L; Le, XY; Liu, QY; Liu, YJ; Qi, YY | 1 |
| Beumer, H; Hoepelman, AI; Rozenberg-Arska, M; Verhoef, J; Visser, MR | 1 |
2 other study(ies) available for sparfloxacin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Sparfloxacin - Cu(II) - aromatic heterocyclic complexes: synthesis, characterization and
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Cytochromes c; DNA; Fluoroquinolones; Humans; Reactive Oxygen Species | 2022 |
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Topics: Anti-Infective Agents; Bacteria; Bacterial Adhesion; Carcinoma; Ciprofloxacin; Fluoroquinolones; Humans; Laryngeal Neoplasms; Quinolones; Respiratory Tract Infections; Trimethoprim; Tumor Cells, Cultured | 1993 |